Archiv für den Monat: August 2021
Corporate card start-up Ramp more than doubles valuation in five months to $3.9 billion
The fundraising is the latest evidence of a fintech boom after the coronavirus pandemic supercharged the category.
Stocks making the biggest moves in the premarket: Best Buy, Palo Alto Networks, Camping World and more
The stocks making the biggest moves in premarket trading include Best Buy, Palo Alto Networks, Camping World, and more.
Corporate card start-up Ramp more than doubles valuation in five months to $3.9 billion
The fundraising is the latest evidence of a fintech boom after the coronavirus pandemic supercharged the category.
Stocks are getting a delta peak and growth slowdown wrong, market bull Jim Paulsen says
The Leuthold Group’s Jim Paulsen suggests the smart money is accurately forecasting Covid-19’s growth impact.
China’s cyberspace regulator lays out two main conditions for companies wanting to go public
Sheng Ronghua, vice minister of the Cyberspace Administration of China, was speaking to reporters about a new „critical information infrastructure“ policy.
Stocks open slightly higher with the Nasdaq jumping to a record
The market started the week on a high note as cyclical shares jumped on optimism that the vaccine approval would clear path for more mandates.
Best Buy shares rise on earnings beat, retailer says consumers are upgrading tech to work at home
The consumer electronics retailer said it has benefited from a healthy consumer, government stimulus and permanent lifestyle changes.
ForexLive European FX news wrap: Hawkish Hawkesby bolsters the kiwi
Forex news from the European trading session – 24 August 2021
Headlines:
Markets:
– NZD leads, EUR lags on the day
– European equities mixed; S&P 500 futures up 0.2%
Headlines:
Markets:
– NZD leads, EUR lags on the day
– European equities mixed; S&P 500 futures up 0.2%
Fauci: Expects Moderna, Johnson & Johnson vaccines to receive complete approval ‚relatively soon‘
Fauci remarks on the COVID-19 vaccine full approval process
This follows the news from yesterday for Pfizer. In case you missed it:
This follows the news from yesterday for Pfizer. In case you missed it: